Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant. The OCS Liver PROTECT randomized clinical trial.
Markmann JF, Aboulijoud MS, Ghobrial RM, Bhati CS, Pelletier SJ, Lu AD et al.
JAMA Surg 2022; 157: 189-198.
Of 293 patients included, machine perfusion reduced the rate of early graft dysfunction (18 versus 31 per cent, P=0.01), and improved use of the liver from donors after cardiac death (51 versus 26 per cent, P=0.007).
Comment: Increasing evidence of the value of this technology.
2 May 2022
Read paperAcademy
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
